View Article

Abstract

Cardiovascular disease (CVD) is a major global health problem and remains one of the leading causes of mortality. Herbal medicines have gained increasing attention due to their therapeutic efficacy, safety, and rich phytochemical composition. The present study was undertaken to formulate and evaluate a polyherbal tablet containing ethanolic extracts of Azadirachta indica (Neem) and Ocimum tenuiflorum (Tulsi) for potential cardiovascular disease management. The plant materials were extracted using the Soxhlet extraction method, yielding an extraction efficiency of 8%. The obtained extracts were subjected to qualitative phytochemical screening, thin-layer chromatography (TLC), and UV–Visible spectrophotometric analysis. Phytochemical screening confirmed the presence of important bioactive constituents, including alkaloids, flavonoids, phenolic compounds, tannins, saponins, and terpenoids. TLC analysis further confirmed the presence of characteristic phytoconstituents. UV–Visible spectroscopy revealed ?max values of 359 nm for neem and 412 nm for tulsi, with the corresponding spectra included in the Results and Discussion section. Four tablet formulations (F1–F4) were prepared by direct compression and evaluated for pre-compression and post-compression parameters according to standard pharmaceutical procedures. Among all formulations, F3 exhibited the most satisfactory physicochemical characteristics and complied with acceptable quality standards, indicating its suitability as the optimized formulation. The combined presence of bioactive phytochemicals and the favorable evaluation results suggest that the developed polyherbal tablet may serve as a promising complementary herbal formulation for cardiovascular disease management. However, further pharmacological and clinical investigations are required to establish its therapeutic efficacy and safety.

Keywords

Azadirachta indica, Ocimum tenuiflorum, cardiovascular disease, polyherbal tablet, Soxhlet extraction, phytochemical screening, TLC, UV–Visible spectroscopy

Introduction

× Popup Image

. 1.1 Pathophysiology of Cardiovascular Diseases

Cardiovascular diseases are multi factorial in origin. The pathogenesis typically begins with endothelial injury triggered by hyperlipidaemia, hypertension, or toxins such as nicotine.

1.2 Need for Herbal Interventions in Cardiovascular Diseases

Despite major advances in pharmacological therapy—such as beta-blockers, ACE inhibitors, and statin conventional treatments are often associated with side effects and high costs.

1.3 Neem [Azadirachta indica] :


Figure -1.1:  The Neem leaves.

Neem, belonging to the family Meliaceous, has been traditionally employed for its antimicrobial, anti-inflammatory, and antioxidant effects. The plant contains bioactive constituents like azadirachtin, imboiled, cardiovascular diseases (CVDs) such as hypertension, atherosclerosis, myocardial infarction, and stroke are the leading causes of morbidity and mortality worldwide. The search for safe, effective, and affordable natural remedies has turned scientific. Among various medicinal plants used in traditional systems of medicine, Neem (Azadirachta indica) and Tulsi (Ocimum sanctum) have gained considerable attention due to their broad spectrum of pharmacological activities. The global view is changing towards the development and therapeutic use of safer preparations from medicinal plants for controlling various diseases. Azadirachta indica A., Juss, locally famous as “Neem”, is a popular herb for its medicinal value in a wide range of diseases including cardiovascular disorders, such as, hypertension and cardiac arrhythmia [29].

Neem (Azadirachta indica)

   ↓ [Antioxidant, Anti-inflammatory, Lipid-lowering actions]

Tulsi (Ocimum sanctum)

   ↓ [Stress modulation, HDL enhancement, Vaso protection]

Combined Effect

   → [Figure 1.3: Comparative mechanisms of Neem and Tulsi contributing to cardiovascular protection. Endothelial repair, Reduced atherogenesis, Cardio protection]a. Antihyperlipidemic Effects. [40].

1.4 Pharmacological activities of neem: [15]

 

Figure - 1.2 : Different Action of Neem

1.5 Cardiovascular benefits of neem :

a. Hypolipidemic and Antiatherogenic

Neem extracts have demonstrated lipid-lowering effects by reducing total cholesterol, triglycerides, and LDL while increasing HDL levels.

Mechanism: Enhances bile acid excretion and modulates hepatic lipid metabolism.

Evidence: preliminary human trials show neem leaf extract decreases serum cholesterol significantly.

b. Antioxidant and Anti-inflammatory Activity

Neem leaves contain potent antioxidants such as quercetin and nimbolide that neutralize free radicals, preventing oxidative stress—a major contributor to endothelial dysfunction and atherosclerosis.

Mechanism: Inhibition of lipid peroxidation and reduction of C-reactive protein levels.

c. Antihypertensive Activity

Studies suggest neem extracts cause vasodilation and reduce blood pressure through calcium channel blockade and nitric oxide modulation. Human relevance: Small clinical studies indicate a mild but sustained reduction in systolic and diastolic blood pressure.

d. Antithrombotic and Anti-platelet Effects

Neem may prevent platelet aggregation and thrombosis formation, reducing risk of myocardial infarction and stroke..

e. Hypoglycaemic and Insulin-Sensitizing Effects

By improving glucose metabolism, neem indirectly helps prevent diabetic cardiovascular complications.

1.6 Tulsi [Ocimum sanctum]

Plant Tulsi  (Ocimum  sanctum  Linn.)  belongs  to  the Lamiacae family which is known for its specific aromatic fragrance  and  medicinal  values  in  traditional  medicine system.  Tulsi  considered  as  the  sacred  plant  in  Indian subcontinent.  Its  medicinal  properties  have  been mentioned  in  the  ancient  medicinal  texts  of  various civilizations of the world [1]..

Figure- 1.3 : The Plant and flower of Tulsi

Pharmacological Active Components:

Tulsi contains several bioactive compounds contributing to its cardiovascular benefits:

Eugenol – an antioxidant and anti-inflammatory agent that protects cardiac tissue.

Ursolic acid – improves lipid metabolism and reduces atherosclerotic plaque formation.

Rosmarinic acid – exerts antioxidant and endothelial-protective effects.

Apigenin and Luteolin – flavonoids with potent free radical scavenging properties.

1.7 Pharmacological Activities of Tulsi :

- Cardioprotective effect, Anti-inflamatory activity ,Anti-diabetic effect ,Anti-ulcer activity ,

Anti-microbial activity , Immunomodulator effect , Hypolipidemic effect [15

METHOD AND MATERIALS

Materials used in the experiment

Table - 1 : List of chemicals

MATERIALS

MANUFACTURER

Neem leaves

LCIT medicinal garden ,Bilaspur

Tulsi leaves

LCIT medicinal garden ,Bilaspur

Lactose

Loba Chemie Pvt.Ltd, Mumbai India

Dicalcium phosphate

Burgoyne Burbidges & Co.Pvt ,Mumbai,India

Maize starch

Loba Chemie Pvt.Ltd, Mumbai India

Sodum starch glycolate

Molychem,Mumbai ,India

Magnesium stearate

Molychem,Mumbai ,India

Talc

Loba Chemie Pvt.Ltd, Mumbai India

Ethanol

Changshu Hongheng Fin Chemical Co.Ltd

1] Collection of plant materials

In the present research work Neem and Tulsi leaves were collected from LCIT medicinal garden Bilaspur and authenticated by the head of the department of botany ,GGU, Bilaspur, Chhattisgarh, India.

Plant Profile of Neem and Tulsi

1. Neem

Botanical Name - Azadirachta indica A. Juss.

Common Names - Neem, Indian lilac, Margosa, Nim.

Family - Meliaceae

Genus - Azadirachta

Species - Azadirachta indica

Geographical Distribution: Neem is native to the Indian subcontinent and is widely cultivated in tropical and subtropical regions. It grows well in dry climates and is drought tolerant.

Botanical Description: Neem is a medium-to-large evergreen tree, commonly about 15–20 m tall. It has a straight trunk with rough grey-brown bark. The leaves are alternate and pinnately compound, bearing several narrow, serrated leaflets. Its flowers are small, white, fragrant, and arranged in axillary panicles. The fruit is an oval yellow drupe containing a single seed.

Parts Used : Leaves ,Bark, Seed ,Seed oil, Flowers, Fruits.

Major Phytoconstituents; Azadirachtin, nimbin, nimbidin, nimbolide, gedunin, quercetin, tannins, flavonoids, limonoids, and fatty acids.

Traditional Uses: Neem has been traditionally used in Ayurveda for skin disorders, dental hygiene, fever, inflammation, wound care, and infections. It is also used as a natural insecticidal plant product.

2. Tulsi

Botanical Name - Ocimum tenuiflorum L.

Synonym: Ocimum sanctum L.

Common Names - Tulsi, Holy basil, Sacred basil, Tulasi.

Family - Lamiaceae

Genus -Ocimum

Species - Ocimum tenuiflorum

Geographical Distribution: Tulsi is native to the Indian subcontinent and grows widely in tropical and subtropical Asia. It is commonly cultivated in household gardens throughout India and Southeast Asia.

Botanical Description: Tulsi is an aromatic, erect, branched herb or small subshrub, generally 30–90 cm tall. The stem is often hairy and quadrangular. Leaves are opposite, simple, ovate, serrated, and strongly aromatic. Flowers are small, white to pale purple, arranged in terminal spikes. The fruit consists of four small nutlets.

Parts Used : Leaves, Aerial parts ,Seeds ,Roots ,Essential oil

Major Phytoconstituents: Eugenol, methyl eugenol, ursolic acid, rosmarinic acid, linalool, β-caryophyllene, apigenin, orientin, vicenin, tannins, and flavonoids.

Traditional Uses: Tulsi is widely used in Ayurveda for cough, cold, fever, respiratory disorders, stress, inflammation, and digestive complaints. It is also valued as a sacred plant in India.

2]  Extraction of Neem and Tulsi using Soxhlet apparatus

Procedure :

Preparation of hydroalcoholic extract (Soxhlet Extraction)

Materials Needed:

  • Neem powder (250g)
  • Tulsi powder (250g)
  • Ethanol (4L)
  • Soxhlet apparatus (including the extraction chamber, siphon, condenser, and boiling flask)
  •  Heating mantle or water bath (set to 65°C)
  • Separatory funnel (for separating extracted solution, if needed)
  • Filter paper (if needed for purification of extract)
  • Weighing balance (for accurate measurement)

Procedure:

A. Preparation:

  • 250g of Neem powder and Tulsi powder grinded them coarsely to increase the surface area for extraction.
  • The extraction chamber was cleaned and properly fitted to the condenser and boiling flask.

B. Solvent Preparation:

  • 2L of ethanol measured and poured it into the boiling flask of the Soxhlet apparatus. Ethanol will act as the solvent for the extraction.

C. Loading the Extractor:

  • The powder (250g) into the extraction thimble (usually a cellulose thimble). This thimble will hold the plant material during the extraction process.
  • Inserted the thimble containing the powder into the Soxhlet extraction chamber.

D. Assembling the Soxhlet Apparatus:

  • The Soxhlet chamber connected to the condenser, ensuring that the cooling water flows properly to prevent overheating.
  • The boiling flask beneath the extraction chamber was fitted.

E. Heating :

  • Placed the boiling flask with ethanol on a heating mantle or water bath. Fixed the temperature to 65°C. The solvent (methanol) will begin to evaporate and condense in the Soxhlet chamber.
  • The ethanol vapors were condensed into the extraction chamber, where they were dissolved the active compounds from the neem and tulsi powder. The condensed l will then siphon back into the boiling flask.

F. Extraction Process:

  • The process was continued for 12 hours, during which time the methanol will repeatedly extract the compounds from the neem and tulsi powder. The cycle of boiling, condensation, and siphoning should occur continuously during this period.
  • The extraction chamber was filled with solvent, and after a certain amount of time, the solvent was siphon back into the boiling flask, allowing fresh solvent to extract the neeem’s and tulsi’s active compounds.

G. Completion of Extraction:

  • After 12 hours, the extraction process stopped. The methanol was have extracted the desired compounds from the neem and tulsi powder.

H. Post-Extraction:

  • The boiling flask from the heating source was removed. If needed. The extract can be concentrated further by removing the solvent (methanol) under reduced pressure using a rotary evaporator or simply evaporating it under low heat if desired.

I. Final Steps:

  • Once the ethanol is removed, the concentrated neem and tulsi extract was collected.

J. Preliminary phytochemical screening of HA extracts

i. Saponins Test

Saponins are glycosides with foaming properties when shaken with water. Here are the chemicals commonly used in their detection:

a) Frothing Test:

  • Distilled Water: Used to extract saponins from the plant material by boiling or  soaking.
  • Test: Shake the plant extract with water and observe if foam persists, indicate the presence of saponins.

b) Frothing with Alcohol:

  • Ethanol or Methanol: Solvent used for extraction.
  • Test: After shaking the extract with alcohol, foam formation indicates the presence of saponins.

ii. Tannins Test

Tannins are polyphenolic compounds that often form precipitates with metal salts. The following reagents are commonly used for tannin detection:

a) Ferric Chloride (FeCl₃) Test:

 • Ferric Chloride (FeCl₃): A reagent that reacts with tannins to form a blue,  green, or black color.

 • Test: Add a few drops of ferric chloride solution to the plant extract. A color change to blue, green, or black indicates the presence of tannins.

b) Lead Acetate Test:

  • Lead Acetate (Pb(C₂H₃O₂)₂): Forms a white precipitate with tannins.

  • Test: Add lead acetate solution to the plant extract. A white precipitate indicates tannins.

iii. Alkaloids Test

Alkaloids are nitrogenous organic compounds with pharmacological effects, and several reagents are used to detect them. Common tests for alkaloids include:

a) Mayer's Test:

  • Mayer’s Reagent: A solution of potassium mercuric iodide (KHI).
  • Test: Add Mayer's reagent to the plant extract. A creamy white  indicates the presence of alkaloids.

b) Dragendorff's Test:

  • Dragendorff's Reagent: A solution of bismuth nitrate in acetic acid, usually combined with KI.
  • Test: Add Dragendorff’s reagent to the extract. A bright orange or reddish- brown precipitate indicates            the presence of alkaloids.

c) Wagner's Test:

  • Wagner's Reagent: A solution of iodine (I₂) in potassium iodide (KI).
  • Test: Add Wagner's reagent to the plant extract. A reddish-brown precipitat  indicates alkaloids.

d) Hager's Test:

  • Hager's Reagent: A solution of picric acid (C₆H₃(NH₂)O₂).
  • Test: Add Hager’s reagent to the extract. A yellow precipitate indicates the  presence of alkaloids.

e) Tannic Acid Test:

  • Tannic Acid: In some cases, tannic acid is used to precipitate alkaloids,  particularly in qualitative tests.
  • Test: Add tannic acid to the extract. A precipitate indicates alkaloids.

f) Sulfuric Acid Test:

  • Concentrated Sulfuric Acid: A strong acid that may cause alkaloids to form a colored solution.
  • Test: Add concentrated sulfuric acid to the extract. If alkaloids are present, reddish, orange, or purple color may develop, depending on the alkaloid.

3] TLC of Extract

Procedure : The ethanolic extracts of neem and tulsi were analyzed by Thin Layer Chromatography (TLC) using pre-coated silica gel 60 F254 plates. Approximately 10 mg of each extract was dissolved in 1 mL methanol, and the solutions were applied as small spots on the TLC plate using a capillary tube. The plate was developed in a solvent system of Toluene : Ethyl acetate  (5:4:1, v/v) until the solvent front migrated about 8 cm. The plate was then removed, air-dried, and examined under UV light at 254 nm and 366 nm. The separated spots were observed, and the Rf values were calculated using the formula:

Rf = Distance travelled by the compound / Distance travelled by the solvent front

4] UV- Spectroscopy of Extract

Procedure :Prepare extract solution: dissolve 100 mg extract in 100 mL ethanol.Filter the solution using Whatman No. 1 filter paper.Switch on the UV–Visible spectrophotometer and allow it to warm up.Fill a quartz cuvette with methanol and set it as the blank.Scan the sample solution from 200–800 nm. Record the wavelength of maximum absorbance (λmax).Measure absorbance at the selected λmax. Use the absorbance value for estimation or comparison of the extract.Common Wavelength Range Extract Approximate λmax range, Neem extract 200–800 nm , Tulsi extract 200–800 nm.

5] Selection and Compatibility of Excipients :

Procedure :Take equal quantities of Neem extract, Tulsi extract, and selected excipient.Mix each combination separately in small airtight vials.Keep one set at room temperature and one set at accelerated condition, such as 40 ± 2°C and 75 ± 5%  relative humidity, for about 2–4 weeks.Observe for: Change in colour, Change in odour ,Caking or liquefaction ,Moisture absorption, Change in flow property ,Change in tablet hardness or friability ,Compare the mixtures with freshly prepared samples.

Compatibility of Neem and Tulsi Extracts with Excipients :

Neem extract + Lactose - Compatible when extract is properly dried.

Tulsi extract + Lactose - Compatible when protected from moisture.

Neem/Tulsi extract + DCP - Compatible in dry tablet formulation.

Neem/Tulsi extract + Maize starch - Compatible and useful for wet granulation.

Neem/Tulsi extract + SSG - Compatible; supports rapid disintegration.

Neem/Tulsi extract + Magnesium stearate - Compatible in small amount.

Neem/Tulsi extract + Talc - Compatible and improves granule flow.

6] Prepartion of Granules via Wet Granulation Technique

Procedure :Sieve neem extract, tulsi extract, lactose, DCP, and SSG separately. Mix neem extract + tulsi extract + lactose + DCP + SSG uniformly. Prepare 10% maize-starch paste using maize starch and purified water.Add starch paste slowly to the powder blend and mix until a cohesive wet mass forms.Pass wet mass through sieve No. 12 or 16 to make wet granules. Dry granules at 40–50°C until they are dry.Pass dried granules through sieve No. 20. Add talc and magnesium stearate; mix gently for 2–3 minutes.Compress the lubricated granules into 420 mg tablets.

Preparation of 10% starch paste

Procedure :Take maize starch as per needed.Mix it with cold water to make a smooth slurry.Heat few mL dis.water separately. Add starch slurry slowly into hot water while stirring.Heat and stir for 3-5 minutes until a smooth paste forms , Cool slightly.Add the paste slowly to the powder mixture to preapare wet granules.

Evalution of Granules

Preformulation studies

Bulk density : Bulk density was carried out in 100 ml dried measuring cylinder. Pouring of dried granules in measuring cylinder and calculated by using the following formula;

Bulk density = Mass of the granules/Bulk volume of the granules

Tapped density ; Tapped density was carried out by pouring of dried granules in 100 ml measuring cylinder.100 tapping was done, note down the volume and calculate by using the following formula;

Tapped density= Granules weight/Volume of tapped granules

Hausner’s ratio : Hausner’s ratio is the ratio of the tapped density of granules to the bulk density of granules. Calculated by using the following formula.

Hausner’s ratio= Tapped density/Bulk density

Carr’s index

Carr’s index or compressibility index is determined by the following formula

Carr’s index[%]= Tapped density –Bulk density /Tapped density ×100

Angle of repose : Angle of repose was determined by using the funnel method. Following formula was used to calculate the angle of repose

ϴ = Tan-1[h/r]

Where  h = height of granule cone formed. , r = radius of the granule cone formed.  

Table - 2: Scale of flowability

 7] Compression of Tablets : Check granules ensure that are dry and free –flowing. Clean the machine and Select punch and die . 8-10mm for 420mg tablet.Fill the hopper.Adjust tablet weight.Set Compression force then Prepare trial tablets.Check trial tablets ,compress full batch.Collect and store tablets .

Physical evalution of tablets ;

General appearance : The general appearance and color of tablets were found by visual  determination.

Weight variation test : The weight variation test was performed by following procedure. Weigh 20 tablets individually and consider as X1, X2,X3,…. .X20.  Determine the average weight of 20 tablets X= (X1+X2+X3+….+X20)/20. The individual weight was compared with the upper limit and lower limit. Not more than two of the tablets differs from the average weight by more than the % error listed, and no tablets differ by more than double that percentage. Results are shown in table 8. 

Table - 3 : Weight variation tolerance

S.NO.

Average weight of tablets [mg]

Max.% difference is allowed

1

80 or less

10%

2

80-250

7%

3

More than 250

5%

Hardness and thickness test: For each formulation, the hardness and thickness of 20 tablets were determined. Hardness test was determined by Monsanto hardness tester and the thickness of tablets was determined by Vernier Calipers. Results are shows in table 8.

Friability test : Friability of a tablets can determine in a laboratory by Roche friabilator. The friabilator consists of plastic chamber that rotates at 25rpm, dropping the tablets through a distance of six inches in the friabilator, which is then operated for 100 revolutions. The tablets are reweighed. Compress tablets loss less than 0.5% to 1.0% of the tablet weight are considered acceptable. Results are shown in table 8.

Disintegration time : This test was a time required for the tablet to separate into particles, the disintegration test measure only of the time required under a given set of a conditions for a group of tablets to disintegrate into particles. This test was performed to identify the disintegration of tablet in a specific time period. Results are shown  in table 8.

Tablets - 4 : Formulation chart for the preparation of table

ngreedients (mg)

F1

F2

F3

F4

Neem extract

60

60

60

60

Tulsi extract

60

60

60

60

Lactose

135

120

125

90

DCP

90

105

120

135

Maize starch

45

40

20

30

SSG

10

15

15

25

Magnessium stearate

10

10

10

10

Talc

10

10

10

10

 

 
 
   

15.Monsanto Hardness Tester Testing for Hardness

Figure- 4.1: Evalution’s

RESULT AND DISCUSSION

5.1 Physicochemical Evalution of plant materials

5.1.1 Percentage yield of all the hydroalvoholic plant extract Roche Friabilator

The percentage yield of HA plant extract are given in the Table.

  • Dried powder used     = 250g
  • Dried extract obtain    = 20g
  • %yield = 20/250×100 = 8%         

Table - 5 : Extract obtain

Name of the plant Drug

Powdered plant drug [gm]

Solvent used ethanol

Neem

20gm

2L

Tulsi

20gm

2L

5.1.2. Preliminary Phytochemical screening of HA plant extract

Table - 6: Phytochemical Test

Constituent

Test

Tulsi

Neem

Observation

Alkaloids

Mayer’s test

+

+

Cream or pale yellow

Flavonids

Shioda test

+

+

Reddish colour

Tannins

Ferric chloride test

+

+

Blue-black/ greenish colour

Phenolic compounds

Ferric chloride test

+

+

Blue- green colour

Saponins

Foam test

+

+

Persistent foam for 10 -15 min

Terpenoids

Salkowaski test

+

+

Reddish  - brown ring at interface

Glycoside

Keller killiani test

+

+

Brown ring at the interface

5.1.3 . Evaluation of Powder Blend/ Granules /Preformulation Parame

Table -7:  Preformulation Evalution

Preformulation parameters

F1

F2

F3

F4

Angle of Repose

32.5

32.5

33.7

33.7

Bulk density

0.42

0.43

0.41

0.44

Tapped density

0.50

0.51

0.49

0.52

Hausner’s ratio

1.19

1.19

1.20

1.18

Carr’s Index

16.00

15.69

16.33

15.38

    5.1.4. Post Formulation Parameters

Table - 8:  Post formulation Evalution

Evaluation parameter

F1

F2

F3

F4

Wt. Variation

400 [-4.76%]

410 [ -2.38%]

425 [ +1.19%]

430  [+2.38]

Friability

0.79%

0.80%

0.78%

0.81%

Hardness kg/cm2

3.5 kg/cm2

3.8 kg /cm2

4.0 kg/cm2

4.0 kg/cm2

Disintegration

10

11

12

12

Thickness

3.8 mm

4 mm

4 mm

4 mm

5.1.5. Experimental UV- Visible absorption Data for Neem extract

Table - 9:  UV-absorption /Wavelength for neem extract

Peak No.

Wavelength λmax.

Absorbance

Peak Shape

1.

318 nm

0.56

Sharp, distinct

2.

359 nm

0.97

Sharp, High Intensity

3.

410 nm

0.81

Sharp

4.

672 nm

0.28

Sharp

          

 

 

 

 

Figure- 5.1: UV-Graph of Neem extract

Table - 10 : UV- absorption / Wavelength for Tulsi

Peak No.

Wavelength [λmax]

Absorbance

Peak Shape

1.

311 nm

0.1578

Sharp

2.

354 nm

0.3419

Sharp

3.

412 nm

0.4994

Sharp, High Intensity

4.

665 nm

0.1916

Sharp

 

 

 

 

Figure- 5.2: UV- Graph of  Tulsi extract

5.1.6 Determination of λmax.

The absorotion spectrum of pure drug was scanned 200-800 nm with 10mg/ml prepared in ethanol .The λmax. of  Neem and Tulsi was to be 359 and 412 nm.

5.1.7 Observation table :     

Table- 11: Compound identified in Neem extract

Sr. No.

Compound

1.

Salannin

2.

4-cyclooctane-1-ol,8,8’-(iminodi-2,1-phenylene)bis (C28H35NO2)

3.

Azadirectin

4.

Nimbin, nimbinin

5.

Germanicol [C30H50O]

6.

Phytol [C30H50O]

                              Table- 12 : Compound identified in Tulsi extract

Sr. No.

Compound

1.

Cirsiliol

2.

Cirsimaritin

3.

Eugenol

4.

Rosamaric acid

5.

Isothymusin

6.

Carvacrol

CONCLUSION

Neem (Azadirachta indica) and Tulsi (Ocimum sanctum), which are adored in ancient Ayurvedic medicine, have shown promising pharmacological properties as natural treatments. Their broad range of therapeutic actions, including antibacterial, anti inflammatory, antioxidant, hepatoprotective, antidiabetic, and immunomodulatory properties, make them essential resources in current phytotherapy. Neem includes bioactive chemicals such azadirachtin, nimbin, and nimbidin, which help it fight bacteria, viruses, and fungal infections. Similarly, Tulsi contains eugenol, ursolic acid, and rosmarinic acid, which are known to have adaptogenic, cardioprotective, characteristics. and antistress Both herbs have showed promise in preclinical and clinical trials for treating chronic ailments such as diabetes, cardiovascular disease, and respiratory disorders. Their usage as complementary medicines may lessen reliance on synthetic pharmaceuticals. Similarly, Tulsi is known for its adaptogenic, antibacterial, antioxidant, hepatoprotective, and anti diabetic properties. Key phytochemicals such as eugenol, ursolic acid, and rosmarinic acid help it manage stress, metabolic disorders, respiratory ailments, and infections. Both herbs have minimal toxicity profiles and offer interesting alternatives or supplementary options to synthetic pharmaceuticals, particularly for designing safe, multi-targeted treatments. Their synergistic potential is being investigated in polyherbal formulations to improve medicinal outcomes. However, despite widespread traditional use and preliminary scientific evidence, more in depth research, including clinical trials and extract standardization, is required to ensure uniform dose, efficacy, and safety. Finally, Neem and Tulsi are significant therapeutic plants with solid pharmacological foundations and promising future use in evidence-based integrative healthcare systems. Further research could open up more targeted applications and assist their widespread acceptance in modern medicine.

REFERENCES:

  1. Wealth of India. CSIR, Publication and information directorate, New Delhi, 1991; VII: 79-89.
  2. WHO Monogram on selected medicinal plants. Dr Xiaorui Zhang, Acting Coordinator, Traditional Medicine, Department of Essential Drugs and Medicines Policy, World Health Organization. Geneva, 2002; Vol 2: 206-216.
  3. Mondal S, MirdhaBR, Mahapatra SC.The science behindsacredness of Tulsi  (Ocimum sanctum Linn).  Indian J Physio Pharmacol, 2009; 53: 291-302
  4. 4 . Abdul Jabbar Shah, Anwarul-Hassan Gilani, Hashim Muhammad Hanif, Saeed Ahmad, Sana Khalid and Ishfaq A. Bukhari, 2014
  5. Bhargava KP, Singh N. Antistress activity of Ocimum sanctum Lin. Indian J Med. Res, 1981; 73: 443-451.
  6. Devi PU, Ganasoundari A. Radioprotective effect of leaf extract of Indian medicinal plant Ocimum sanctum. Indian J Exp Biol, 1995; 33:205-8.
  7. Sharma M, Kishore K, Gupta SK, Joshi S, Arya DS. Cardioprotective potential of Ocimum sanctum in isoproterenol induced myocardial infarction in rats. Mol Cell Biochem, 2001; 225(9): 75-83.
  8. Sood S, Narang D, Dinda, AK, Maulik SK. Chronic oral administration of Ocimum sanctum Linn. augments cardiac endogenous antioxidants and prevents isoproterenol-induced myocardial necrosis in rats. J Pharmac Pharmacol, 2005; 57: 127133.
  9. Arya D S, Nandave M, Ojha S K, Kumari S, Joshi S, Mohanty I. Myocardial salvaging effects of Ocimum sanctum in experimental model of myocardial necrosis: a haemodynamic, biochemical and histoarchitectura Assess-ment. Current Science, 2006; 91: 10667-672.
  10. 10.Suanarunsawat T, Ayutthaya WD, Songsak T, Thirawarapan S, Poungshompoo S. Lipid-lowering and antioxidative activities of aqueous extracts of Ocimum sanctum L. leaves in rats fed with a high-cholesterol diet. Oxid Med Cell Longev, 2011; doi:10.1155/2011/962025.
  11. 11.Jones B, Kenward MG. Design and analysis of cross-over trials. 2nd Ed. Chapman & Hall/CRC. New York. US. 2003.
  12. 12.Singh S, Majumdar DK, Yadav MR. Chemical and pharmacological studies of Ocimum sanctum fixed oil. Indian J Exp Biol, 1996; 34: 1212-1215.
  13. 13.Rai V, Iyer U, Mani UV. Plant Food. Effect of Tulasi (Ocimum sanctum) leaf powder supplementation on blood sugar levels, serum lipids and tissue lipids in diabetic rats. Hum Nutri, 1997; 50:9-16.
  14. 14.Campbell, W.B., D. Gebremedhin, P.F. Pratt and D.R. Harder, 1996. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circul. Res., 78: 415-423.
  15. Khosla P, Gupta A, Singh J. A study of cardiovascular effects of Azadirachta indica (neem) on isolated perfused heart preparations. Indian J Physiol Pharmacol. 2002 Apr;46(2):241-4. PMID: 12500501.
  16. 16.Gupta S, Mediratta PK, Singh S, Sharma KK, Shukla R. Antidiabetic, anti hypocholesterolaemia and antioxidant effect of Ocimum sanctum (Linn) seed oil. Indian J Exp Biol, 2006; 44: 300304.
  17. 17.Talayero BG, Sacks FM. The role of triglycerides in atherosclerosis. Curr Cardiol Rep. 2011; 13(6):544-52.
  18. 18.Saggini A, Anogeianaki A, Angelucci D, et al. Cholesterol and vitamins: revisited study. J Biol Regul Homeost Agents. 2011; 25(4):505-15.
  19. Zong, H. Cao, and F. Wang, “Anticancer polysaccharides from natural resources: a review of recent research,” Carbohy drate Polymers, vol. 90, no. 4, pp. 1395–1410, 2012. 
  20. T. Efferth and E. Koch, “Complex interactions between Phyto chemicals. The Multi-Target Therapeutic concept of Phytother apy,” Current Drug Targets,vol.12,no.1,pp.122–132,2011.
  21. Schmutterer H (1990) Properties and potentials of natural pesticides from neem tree. Annual eview of Entomol 35:271–298.
  22. Ajayi FA (2002) Formulation and promotion of neem—seed derived Biopesticides as alternative to persistent organic pollutants (POPs) for the control of vegetable crop pests. In: Ukwe CN, Folorunso AO, Ibe AC, Z Z, N.E.S NES, Sieghart L (eds) Sustainable industrial utilization of neem tree (Azadirachta indica) in Nigeria. UNIDO Regional Development Centre, Lagos, pp 83–90.
  23. Arumugam, A., Agullo, P., Boopalan, T., Nandy, S., Lopez, R., Gutierrez, C., ... Rajkumar, L. (2014). Neem leaf extract inhibits mammarycarcino -genesis by altering cell pro liferation, apoptosis, and angiogenesis. Cancer Biology and Therapy, 15(1), https://doi.org/10.4161/cbt.26604. 26–34.
  24. Sinha, K.C., S.S. Riar, R.S. Tiwary, A.K. Dhawan and J. Bardhan et al., 1984. Neem oil as a vaginal contraceptive. Indian J. Med. Res., 79: 131-136.
  25. Tep-Areenan, P. and P. Sawasdee, 2011. The vasorelaxant effects of Anaxagorea luzonensis A. Grey in the rat Aorta. Int. J. Pharmacol., 7: 119-124.
  26. Rupani, R., & Chavez, A. (2018). Medicinal plants with traditional use: Ethnobotany in the Indian subcontinent. Clinics in Dermatology, IJIRT183855 36(3),1016/j.clindermatol.2018.03.005.
  27. Deng, Y.x., Cao, M., Shi, D.x., Yin, Z.q., Jia,R.y., Xu, J., … & Zhao, J. (2013). Toxicological evaluation of neem (Azadirachta indica) oil: Acute and subacute toxi city. Environmental Toxicology and Pharmacology, 35(2), 240–246.
  28. 28 .Atal CK, Kapoor BM. Cultivation and utilization of medicinal plants (Eds. PID CSIR), 1989. 2. [11] Siddiqui HH. Safety of herbal drugs-an overview. Drugs News & Views 1993; 1(2): 710.
  29. Khan, M., A.U. Khan and A. Gilani, 2014. Blood pressure lowering effect of Morus alba is mediated through Ca++ antagonist pathway. Int. J. Pharmacol., 10: 225-230.
  30. Ocimum sanctum. The Indian home remedy. In: Current Medical Scene, March-April 1992 (Edited and published by S. Rajeshwari, Cipla Ltd., Bombay Central, Bombay).
  31. Sen P. Therapeutic potentials of Tulsi : from experience to facts. Drugs News & Views 1993; 1(2):15–21.
  32. Ayurvedic Pharmacopeia of India, Government of India. 1(2), 131-132. Ali A. Textbook of Pharmacognosy. New Delhi, India: Publication and Information Directorate; 1993. 
  33. Shah, A.J. and A.H. Gilani, 2011. Blood pressure lowering effect of the extract of aerial parts of Capparis aphylla is mediated through endothelium-dependent and independent mechanisms. Clin. Exp. Hypertens., 33: 470-477.
  34. Kokate C, Purohit AP, Gokhale SB. Pharmacognosy. Maharashtra, India: Nirali Prakashan; 2010.
  35. Bilton, J.N., H.B. Broughton, P.S. Jones, S.V. Ley, Z. Lidert, E.D. Morgan, H.S. Rzepa, R.N. Sheppard, A.M.Z. Slawin & D.J. Williams. 1987. An X-ray crystallographic, mass spectroscopic, and NMR study of the limonoid insect antifeedant azadirachtin and related derivatives. Tetrahedron 43: 2805-2815.
  36. Rembold, H & R.S. Annadurai. 1993. Azadirachtin inhibits proliferation of Sf9 cells in monolayer culture. Z. Naturforsch. 48c: 495-499.
  37. Sarkar A, Lavania SC, Pandey DN, Pant MC. Changes in the blood lipid profile after administration of Ocimum sanctum (Tulsi) leaves in the normal albino rabbits. Indian J Physiol Pharmacol. 1994;38(4):311-2.
  38. Suanarunsawat T, Boonnak T, Na Ayutthaya WD, Thirawarapan S. Antihyperlipidemic and cardioprotective effects of Ocimum sanctum L. fixed oil in rats fed a high fat diet. J Basic Clin Physiol Pharmacol. 2010;21(4):387400.
  39. Meghwani H, Prabhakar P, Mohammed SA. Beneficial Effect of Ocimumsanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension inRats. Medicines (Basel). 2018;5(2):34.
  40. Sadana B, Hira CK 1997. Effect of income and season onthe nutrient intake of rural women in central plainzone and Kandi area of Punjab. Ind J Reol, 24: 66-74.

Reference

  1. Wealth of India. CSIR, Publication and information directorate, New Delhi, 1991; VII: 79-89.
  2. WHO Monogram on selected medicinal plants. Dr Xiaorui Zhang, Acting Coordinator, Traditional Medicine, Department of Essential Drugs and Medicines Policy, World Health Organization. Geneva, 2002; Vol 2: 206-216.
  3. Mondal S, MirdhaBR, Mahapatra SC.The science behindsacredness of Tulsi  (Ocimum sanctum Linn).  Indian J Physio Pharmacol, 2009; 53: 291-302
  4. 4 . Abdul Jabbar Shah, Anwarul-Hassan Gilani, Hashim Muhammad Hanif, Saeed Ahmad, Sana Khalid and Ishfaq A. Bukhari, 2014
  5. Bhargava KP, Singh N. Antistress activity of Ocimum sanctum Lin. Indian J Med. Res, 1981; 73: 443-451.
  6. Devi PU, Ganasoundari A. Radioprotective effect of leaf extract of Indian medicinal plant Ocimum sanctum. Indian J Exp Biol, 1995; 33:205-8.
  7. Sharma M, Kishore K, Gupta SK, Joshi S, Arya DS. Cardioprotective potential of Ocimum sanctum in isoproterenol induced myocardial infarction in rats. Mol Cell Biochem, 2001; 225(9): 75-83.
  8. Sood S, Narang D, Dinda, AK, Maulik SK. Chronic oral administration of Ocimum sanctum Linn. augments cardiac endogenous antioxidants and prevents isoproterenol-induced myocardial necrosis in rats. J Pharmac Pharmacol, 2005; 57: 127133.
  9. Arya D S, Nandave M, Ojha S K, Kumari S, Joshi S, Mohanty I. Myocardial salvaging effects of Ocimum sanctum in experimental model of myocardial necrosis: a haemodynamic, biochemical and histoarchitectura Assess-ment. Current Science, 2006; 91: 10667-672.
  10. 10.Suanarunsawat T, Ayutthaya WD, Songsak T, Thirawarapan S, Poungshompoo S. Lipid-lowering and antioxidative activities of aqueous extracts of Ocimum sanctum L. leaves in rats fed with a high-cholesterol diet. Oxid Med Cell Longev, 2011; doi:10.1155/2011/962025.
  11. 11.Jones B, Kenward MG. Design and analysis of cross-over trials. 2nd Ed. Chapman & Hall/CRC. New York. US. 2003.
  12. 12.Singh S, Majumdar DK, Yadav MR. Chemical and pharmacological studies of Ocimum sanctum fixed oil. Indian J Exp Biol, 1996; 34: 1212-1215.
  13. 13.Rai V, Iyer U, Mani UV. Plant Food. Effect of Tulasi (Ocimum sanctum) leaf powder supplementation on blood sugar levels, serum lipids and tissue lipids in diabetic rats. Hum Nutri, 1997; 50:9-16.
  14. 14.Campbell, W.B., D. Gebremedhin, P.F. Pratt and D.R. Harder, 1996. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circul. Res., 78: 415-423.
  15. Khosla P, Gupta A, Singh J. A study of cardiovascular effects of Azadirachta indica (neem) on isolated perfused heart preparations. Indian J Physiol Pharmacol. 2002 Apr;46(2):241-4. PMID: 12500501.
  16. 16.Gupta S, Mediratta PK, Singh S, Sharma KK, Shukla R. Antidiabetic, anti hypocholesterolaemia and antioxidant effect of Ocimum sanctum (Linn) seed oil. Indian J Exp Biol, 2006; 44: 300304.
  17. 17.Talayero BG, Sacks FM. The role of triglycerides in atherosclerosis. Curr Cardiol Rep. 2011; 13(6):544-52.
  18. 18.Saggini A, Anogeianaki A, Angelucci D, et al. Cholesterol and vitamins: revisited study. J Biol Regul Homeost Agents. 2011; 25(4):505-15.
  19. Zong, H. Cao, and F. Wang, “Anticancer polysaccharides from natural resources: a review of recent research,” Carbohy drate Polymers, vol. 90, no. 4, pp. 1395–1410, 2012. 
  20. T. Efferth and E. Koch, “Complex interactions between Phyto chemicals. The Multi-Target Therapeutic concept of Phytother apy,” Current Drug Targets,vol.12,no.1,pp.122–132,2011.
  21. Schmutterer H (1990) Properties and potentials of natural pesticides from neem tree. Annual eview of Entomol 35:271–298.
  22. Ajayi FA (2002) Formulation and promotion of neem—seed derived Biopesticides as alternative to persistent organic pollutants (POPs) for the control of vegetable crop pests. In: Ukwe CN, Folorunso AO, Ibe AC, Z Z, N.E.S NES, Sieghart L (eds) Sustainable industrial utilization of neem tree (Azadirachta indica) in Nigeria. UNIDO Regional Development Centre, Lagos, pp 83–90.
  23. Arumugam, A., Agullo, P., Boopalan, T., Nandy, S., Lopez, R., Gutierrez, C., ... Rajkumar, L. (2014). Neem leaf extract inhibits mammarycarcino -genesis by altering cell pro liferation, apoptosis, and angiogenesis. Cancer Biology and Therapy, 15(1), https://doi.org/10.4161/cbt.26604. 26–34.
  24. Sinha, K.C., S.S. Riar, R.S. Tiwary, A.K. Dhawan and J. Bardhan et al., 1984. Neem oil as a vaginal contraceptive. Indian J. Med. Res., 79: 131-136.
  25. Tep-Areenan, P. and P. Sawasdee, 2011. The vasorelaxant effects of Anaxagorea luzonensis A. Grey in the rat Aorta. Int. J. Pharmacol., 7: 119-124.
  26. Rupani, R., & Chavez, A. (2018). Medicinal plants with traditional use: Ethnobotany in the Indian subcontinent. Clinics in Dermatology, IJIRT183855 36(3),1016/j.clindermatol.2018.03.005.
  27. Deng, Y.x., Cao, M., Shi, D.x., Yin, Z.q., Jia,R.y., Xu, J., … & Zhao, J. (2013). Toxicological evaluation of neem (Azadirachta indica) oil: Acute and subacute toxi city. Environmental Toxicology and Pharmacology, 35(2), 240–246.
  28. 28 .Atal CK, Kapoor BM. Cultivation and utilization of medicinal plants (Eds. PID CSIR), 1989. 2. [11] Siddiqui HH. Safety of herbal drugs-an overview. Drugs News & Views 1993; 1(2): 710.
  29. Khan, M., A.U. Khan and A. Gilani, 2014. Blood pressure lowering effect of Morus alba is mediated through Ca++ antagonist pathway. Int. J. Pharmacol., 10: 225-230.
  30. Ocimum sanctum. The Indian home remedy. In: Current Medical Scene, March-April 1992 (Edited and published by S. Rajeshwari, Cipla Ltd., Bombay Central, Bombay).
  31. Sen P. Therapeutic potentials of Tulsi : from experience to facts. Drugs News & Views 1993; 1(2):15–21.
  32. Ayurvedic Pharmacopeia of India, Government of India. 1(2), 131-132. Ali A. Textbook of Pharmacognosy. New Delhi, India: Publication and Information Directorate; 1993. 
  33. Shah, A.J. and A.H. Gilani, 2011. Blood pressure lowering effect of the extract of aerial parts of Capparis aphylla is mediated through endothelium-dependent and independent mechanisms. Clin. Exp. Hypertens., 33: 470-477.
  34. Kokate C, Purohit AP, Gokhale SB. Pharmacognosy. Maharashtra, India: Nirali Prakashan; 2010.
  35. Bilton, J.N., H.B. Broughton, P.S. Jones, S.V. Ley, Z. Lidert, E.D. Morgan, H.S. Rzepa, R.N. Sheppard, A.M.Z. Slawin & D.J. Williams. 1987. An X-ray crystallographic, mass spectroscopic, and NMR study of the limonoid insect antifeedant azadirachtin and related derivatives. Tetrahedron 43: 2805-2815.
  36. Rembold, H & R.S. Annadurai. 1993. Azadirachtin inhibits proliferation of Sf9 cells in monolayer culture. Z. Naturforsch. 48c: 495-499.
  37. Sarkar A, Lavania SC, Pandey DN, Pant MC. Changes in the blood lipid profile after administration of Ocimum sanctum (Tulsi) leaves in the normal albino rabbits. Indian J Physiol Pharmacol. 1994;38(4):311-2.
  38. Suanarunsawat T, Boonnak T, Na Ayutthaya WD, Thirawarapan S. Antihyperlipidemic and cardioprotective effects of Ocimum sanctum L. fixed oil in rats fed a high fat diet. J Basic Clin Physiol Pharmacol. 2010;21(4):387?400.
  39. Meghwani H, Prabhakar P, Mohammed SA. Beneficial Effect of Ocimumsanctum (Linn) against Monocrotaline-Induced Pulmonary Hypertension inRats. Medicines (Basel). 2018;5(2):34.
  40. Sadana B, Hira CK 1997. Effect of income and season onthe nutrient intake of rural women in central plainzone and Kandi area of Punjab. Ind J Reol, 24: 66-74.

Photo
Roshan Kumar
Corresponding author

Department of Pharmacy, LCIT School of Pharmacy, Bilaspur, CG

Photo
Sudhir Kathane
Co-author

Department of Pharmacy, LCIT School of Pharmacy, Bilaspur, CG

Photo
Ritesh Jain
Co-author

Department of Pharmacy, LCIT School of Pharmacy, Bilaspur, CG

Roshan Kumar*, Sudhir Kathane , Ritesh Jain, Development of Neem and Tulsi Tablets for Cardiovascular Care, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 7, 2647-2666. https://doi.org/10.5281/zenodo.21344921

More related articles
Engineered Bilosomes: Formulation Strategies, Surf...
Nebin Koshy, Sarath S, Sreejith V, Anandhu Dineshan, Akhila P, Ar...
Antibiotic Prophylaxis Practices in Orthopedic Sur...
Adithi G, Anakha Shibu, Amina Ameer, Aksa George, J. S. Venkates...
Phytopharmacology and Characterization of Differen...
Priti Mastud, Swapnali Kasture, Aarti Varne...
A Comprehensive Guide to Topical Cosmetic Science: From Formulation to Global Tr...
Dr. Deepu S, M Afiya Fathima, Jyothika Shamil T, Shifana A, Danushma P Menon, Farseena Thazhathethil...
Review on Phytosomal Gel for Enhanced Topical Drug Delivery...
Vishakha Sawant, Schidanand Angad, Reshma Patil, Vandana Patil, Aditi Dhondre...
Related Articles
Analytical Approaches for the Determination of Antineoplastic Agent: A Review...
Kedar Bhagyesh, Mogal N. K., Ghodake S. R., Dr. Kamble H.V., Dr. Jain P. P., Sonawane A. A....
Advances in Ornidazole-Loaded Microspheres for Improved Therapeutic Efficacy: A ...
Neha Bombilwar, Schidanand Angad, Vandana Patil, Reshama Patil, Gaytri Mapari...
Lifecycle Analysis of Medicines Withdrawn, Restricted, or Label Updated Due to S...
Md Sayeed Anwar, Shyam Lal Yadav, Lakshyadeep Choudhary, Khushi Gupta, Piyush Ranjan Gupta, Robin Si...
Engineered Bilosomes: Formulation Strategies, Surface Modifications, and Deliver...
Nebin Koshy, Sarath S, Sreejith V, Anandhu Dineshan, Akhila P, Arun Raj R, Sudhir M R...
More related articles
Engineered Bilosomes: Formulation Strategies, Surface Modifications, and Deliver...
Nebin Koshy, Sarath S, Sreejith V, Anandhu Dineshan, Akhila P, Arun Raj R, Sudhir M R...
Antibiotic Prophylaxis Practices in Orthopedic Surgery: A Prospective Observatio...
Adithi G, Anakha Shibu, Amina Ameer, Aksa George, J. S. Venkatesh...
Engineered Bilosomes: Formulation Strategies, Surface Modifications, and Deliver...
Nebin Koshy, Sarath S, Sreejith V, Anandhu Dineshan, Akhila P, Arun Raj R, Sudhir M R...
Antibiotic Prophylaxis Practices in Orthopedic Surgery: A Prospective Observatio...
Adithi G, Anakha Shibu, Amina Ameer, Aksa George, J. S. Venkatesh...